HempMy Pet™ Announces a Clinical Trials Study using their Hemp-derived CBD Oil to Manage Pain in Osteoarthritic Dogs

Tuesday, April 2, 2019 Clinical Trials News
Email Print This Page Comment bookmark
Font : A-A+

In Collaboration with Colorado State University College of Veterinary Medicine and Biomedical Sciences, and Downing Center for Pain Management

BOULDER, Colo., April 2, 2019 /PRNewswire/ -- HempMy Pet™, a vertically integrated Colorado Hemp company that grows medicinal

hemp and produces CBD-infused pet products, announces the completion of a clinical trial to assess the impact of hemp-derived Cannabidiol (CBD) on dogs suffering from chronic pain and decreased functionality due to osteoarthritis. Overseen by Robin Downing, DVM, MS, DAAPM, DACVSMR, CVPP, CCRP of the Downing Center for Animal Pain Management in Windsor Colorado, and Lori Kogan, Ph.D. and Peter W. Hellyer, DVM, MS, DACVAA, of Colorado State University College of Veterinary Medicine & Biomedical Sciences, the 90-day study included 30 dogs whose owners administered HempMy Pet™ full-spectrum CBD oil while under Dr. Downing's care. Most of the participating dogs, prior to the study, were pain managed through gabapentin and/or other pain medications. One goal of the study was to, through implementation of CBD, decrease the use of  these other pain medications without increasing pain levels. Prelimiary results from this trial are quite promising. 

Due to the legal ambiguity of CBD, there is a lack of research and knowledge about quality control and appropriate dosage, leaving many pet owners and veterinarians hesitant to try or recommend these products. Yet, as Marc Brannigan, Co-founder and CEO of HempMy Pet™,  explains, "You would not believe the testimonials we have received from our customers over the years. I am thrilled we can now back up these testimonials with clinical research."

Dr. Robin Downing states: "As a pet pain expert, I am always on the lookout for effective strategies to relieve chronic pain in my patients. My commitment to evidence-based medicine prompted my participation in this unique pilot study.  I was delighted to observe that the majority of dogs enrolled in the study demonstrated a clear benefit from taking this CBD product."

Founded in 2016, HM Health, LLC, the manufacturer of HempMy Pet™, offers CBD-infused products for dogs, cats and horses. All products are made with their own, in-house strain-specific, full-spectrum hemp extract from their greenhouses and facilities located in Loveland, Colorado.

Watch for the full publication and exciting documentary. More info will be posted as it becomes available at HempMyPet.com.

About HempMy Pet™HempMy Pet's partnership with Pets Forever is important to the company, whose mission is to help animals live the happiest, healthiest lives possible. "When you give your pets food and treats made from high-quality, organic ingredients infused with the naturally beneficial properties of hemp, you're helping them to feel their best every day and live a long, healthy life," Marc Brannigan, founder. Visit https://www.hempmypet.com/ to learn more.

 

Cision View original content:http://www.prnewswire.com/news-releases/hempmy-pet-announces-a-clinical-trials-study-using-their-hemp-derived-cbd-oil-to-manage-pain-in-osteoarthritic-dogs-300822493.html

SOURCE HempMy Pet™



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store